ANDA 72894, held by Natco Pharma USA. Albuterol Sulfate.
As of Nov 16, 2026, ANDA 72894 (Albuterol Sulfate), held by Natco Pharma USA, was first approved by FDA on Jan 17, 1991, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 17, 1991 | Original application | Approved | None posted |
| Albuterol SulfateEQ 4MG BASE · tablet;oral | Albuterol Sulfate | Discontinued |
| Albuterol SulfateEQ 2MG BASE · tablet;oral | Albuterol Sulfate | Discontinued |
| Jul 16, 1998 | Supplement 7Labeling | Approved | None posted |
| Feb 5, 1998 | Supplement 6Manufacturing | Approved | None posted |
| Oct 29, 1993 | Supplement 5Manufacturing | Approved | None posted |
| Feb 18, 1993 | Supplement 3Labeling | Approved | None posted |
| Nov 5, 1992 | Supplement 2Labeling | Approved | None posted |
| Sep 23, 1992 | Supplement 1Manufacturing | Approved | None posted |
| Jan 17, 1991 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters